vs
agilon health, inc.（AGL）与RXO, Inc.（RXO）财务数据对比。点击上方公司名可切换其他公司
agilon health, inc.的季度营收约是RXO, Inc.的1.1倍（$1.6B vs $1.5B），RXO, Inc.净利率更高（-3.1% vs -12.0%，领先8.9%），agilon health, inc.同比增速更快（3.1% vs -11.9%），RXO, Inc.自由现金流更多（$-9.0M vs $-23.5M），过去两年RXO, Inc.的营收复合增速更高（26.8% vs -1.1%）
agilon health是一家美国医疗保健企业，主要与基层医疗服务提供者合作，为联邦医疗保险覆盖的老年群体提供价值导向型医疗解决方案，为医生提供行政支持、临床工具及风险管理框架，在提升诊疗效果的同时降低医疗成本，业务覆盖美国20余个州。
RXO是总部位于美国的头部运输及物流解决方案供应商，核心业务覆盖货运经纪、大件商品最后一公里配送、运输管理服务与全链路供应链优化支持，主要服务北美制造业、零售业及电商领域的客户。
AGL vs RXO — 直观对比
营收规模更大
AGL
是对方的1.1倍
$1.5B
营收增速更快
AGL
高出15.0%
-11.9%
净利率更高
RXO
高出8.9%
-12.0%
自由现金流更多
RXO
多$14.5M
$-23.5M
两年增速更快
RXO
近两年复合增速
-1.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.6B | $1.5B |
| 净利润 | $-188.9M | $-46.0M |
| 毛利率 | — | — |
| 营业利润率 | -12.3% | -2.9% |
| 净利率 | -12.0% | -3.1% |
| 营收同比 | 3.1% | -11.9% |
| 净利润同比 | -78.5% | -84.0% |
| 每股收益（稀释后） | — | $-0.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AGLRXO
| Q4 25 | $1.6B | $1.5B | ||
| Q3 25 | $1.4B | $1.4B | ||
| Q2 25 | $1.4B | $1.4B | ||
| Q1 25 | $1.5B | $1.4B | ||
| Q4 24 | $1.5B | $1.7B | ||
| Q3 24 | $1.5B | $1.0B | ||
| Q2 24 | $1.5B | $930.0M | ||
| Q1 24 | $1.6B | $913.0M |
净利润AGLRXO
| Q4 25 | $-188.9M | $-46.0M | ||
| Q3 25 | $-110.2M | $-14.0M | ||
| Q2 25 | $-104.4M | $-9.0M | ||
| Q1 25 | $12.1M | $-31.0M | ||
| Q4 24 | $-105.8M | $-25.0M | ||
| Q3 24 | $-117.6M | $-243.0M | ||
| Q2 24 | $-30.7M | $-7.0M | ||
| Q1 24 | $-6.1M | $-15.0M |
营业利润率AGLRXO
| Q4 25 | -12.3% | -2.9% | ||
| Q3 25 | -9.1% | -0.5% | ||
| Q2 25 | -8.3% | — | ||
| Q1 25 | -1.4% | -2.1% | ||
| Q4 24 | -7.1% | -1.4% | ||
| Q3 24 | -9.2% | -1.9% | ||
| Q2 24 | -2.9% | — | ||
| Q1 24 | -0.4% | -1.3% |
净利率AGLRXO
| Q4 25 | -12.0% | -3.1% | ||
| Q3 25 | -7.7% | -1.0% | ||
| Q2 25 | -7.5% | -0.6% | ||
| Q1 25 | 0.8% | -2.2% | ||
| Q4 24 | -6.9% | -1.5% | ||
| Q3 24 | -8.1% | -23.4% | ||
| Q2 24 | -2.1% | -0.8% | ||
| Q1 24 | -0.4% | -1.6% |
每股收益（稀释后）AGLRXO
| Q4 25 | — | $-0.28 | ||
| Q3 25 | — | $-0.08 | ||
| Q2 25 | — | $-0.05 | ||
| Q1 25 | — | $-0.18 | ||
| Q4 24 | — | $-0.17 | ||
| Q3 24 | — | $-1.81 | ||
| Q2 24 | — | $-0.06 | ||
| Q1 24 | — | $-0.13 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $173.7M | $17.0M |
| 总债务越低越好 | $35.0M | $387.0M |
| 股东权益账面价值 | $126.7M | $1.5B |
| 总资产 | $1.3B | $3.3B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.25× |
8季度趋势，按日历期对齐
现金及短期投资AGLRXO
| Q4 25 | $173.7M | $17.0M | ||
| Q3 25 | $171.7M | $25.0M | ||
| Q2 25 | $171.4M | $18.0M | ||
| Q1 25 | $136.9M | $16.0M | ||
| Q4 24 | $188.2M | $35.0M | ||
| Q3 24 | $148.2M | $55.0M | ||
| Q2 24 | $109.5M | $7.0M | ||
| Q1 24 | $111.7M | $7.0M |
总债务AGLRXO
| Q4 25 | $35.0M | $387.0M | ||
| Q3 25 | — | $387.0M | ||
| Q2 25 | — | $387.0M | ||
| Q1 25 | — | $387.0M | ||
| Q4 24 | — | $351.0M | ||
| Q3 24 | — | $352.0M | ||
| Q2 24 | — | $370.0M | ||
| Q1 24 | — | $351.0M |
股东权益AGLRXO
| Q4 25 | $126.7M | $1.5B | ||
| Q3 25 | $306.1M | $1.6B | ||
| Q2 25 | $408.9M | $1.6B | ||
| Q1 25 | $500.3M | $1.6B | ||
| Q4 24 | $471.0M | $1.6B | ||
| Q3 24 | $574.9M | $1.7B | ||
| Q2 24 | $676.6M | $579.0M | ||
| Q1 24 | $689.3M | $582.0M |
总资产AGLRXO
| Q4 25 | $1.3B | $3.3B | ||
| Q3 25 | $1.6B | $3.2B | ||
| Q2 25 | $1.7B | $3.2B | ||
| Q1 25 | $1.9B | $3.3B | ||
| Q4 24 | $1.7B | $3.4B | ||
| Q3 24 | $2.1B | $3.4B | ||
| Q2 24 | $2.2B | $1.8B | ||
| Q1 24 | $2.3B | $1.8B |
负债/权益比AGLRXO
| Q4 25 | 0.28× | 0.25× | ||
| Q3 25 | — | 0.24× | ||
| Q2 25 | — | 0.24× | ||
| Q1 25 | — | 0.24× | ||
| Q4 24 | — | 0.22× | ||
| Q3 24 | — | 0.21× | ||
| Q2 24 | — | 0.64× | ||
| Q1 24 | — | 0.60× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-20.5M | $7.0M |
| 自由现金流经营现金流 - 资本支出 | $-23.5M | $-9.0M |
| 自由现金流率自由现金流/营收 | -1.5% | -0.6% |
| 资本支出强度资本支出/营收 | 0.2% | 1.1% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-119.0M | $-8.0M |
8季度趋势，按日历期对齐
经营现金流AGLRXO
| Q4 25 | $-20.5M | $7.0M | ||
| Q3 25 | $-18.2M | $23.0M | ||
| Q2 25 | $-35.1M | $23.0M | ||
| Q1 25 | $-32.0M | $-2.0M | ||
| Q4 24 | $16.4M | $-7.0M | ||
| Q3 24 | $-7.7M | $-7.0M | ||
| Q2 24 | $-18.7M | $-5.0M | ||
| Q1 24 | $-47.8M | $7.0M |
自由现金流AGLRXO
| Q4 25 | $-23.5M | $-9.0M | ||
| Q3 25 | $-21.3M | $9.0M | ||
| Q2 25 | $-38.3M | $9.0M | ||
| Q1 25 | $-35.8M | $-17.0M | ||
| Q4 24 | $13.2M | $-19.0M | ||
| Q3 24 | $-11.2M | $-18.0M | ||
| Q2 24 | $-22.0M | $-16.0M | ||
| Q1 24 | $-50.9M | $-4.0M |
自由现金流率AGLRXO
| Q4 25 | -1.5% | -0.6% | ||
| Q3 25 | -1.5% | 0.6% | ||
| Q2 25 | -2.7% | 0.6% | ||
| Q1 25 | -2.3% | -1.2% | ||
| Q4 24 | 0.9% | -1.1% | ||
| Q3 24 | -0.8% | -1.7% | ||
| Q2 24 | -1.5% | -1.7% | ||
| Q1 24 | -3.2% | -0.4% |
资本支出强度AGLRXO
| Q4 25 | 0.2% | 1.1% | ||
| Q3 25 | 0.2% | 1.0% | ||
| Q2 25 | 0.2% | 1.0% | ||
| Q1 25 | 0.3% | 1.0% | ||
| Q4 24 | 0.2% | 0.7% | ||
| Q3 24 | 0.2% | 1.1% | ||
| Q2 24 | 0.2% | 1.2% | ||
| Q1 24 | 0.2% | 1.2% |
现金转化率AGLRXO
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -2.64× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AGL
| Medical Services | $1.6B | 100% |
| Other Operating | $2.5M | 0% |
RXO
| Retail Sector | $546.0M | 37% |
| Last Mile | $298.0M | 20% |
| Food And Beverage Sector | $225.0M | 15% |
| Other Sector | $185.0M | 13% |
| Managed Transportation | $133.0M | 9% |
| Automotive Sector | $93.0M | 6% |
